N,N'-Dicyclohexylurea
CAS No. 2387-23-7
N,N'-Dicyclohexylurea( 1,3-Dicyclohexylurea | AURORA KA-3582 | Dicyclohexylurea | Dicyclohexylcarbodiamide | NSC 17013 | DCU )
Catalog No. M27666 CAS No. 2387-23-7
N,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 49 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 166 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN,N'-Dicyclohexylurea
-
NoteResearch use only, not for human use.
-
Brief DescriptionN,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.
-
DescriptionN,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.
-
In Vitro——
-
In Vivo1,3-Dicyclohexylurea (Sprague Dawley rats, 30 mg/kg, Orally, once) shows antihypertensive efficacy when milled to reduce particle size, thus improving dissolution and oral bioavailability.
-
Synonyms1,3-Dicyclohexylurea | AURORA KA-3582 | Dicyclohexylurea | Dicyclohexylcarbodiamide | NSC 17013 | DCU
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2387-23-7
-
Formula Weight224.348
-
Molecular FormulaC13H24N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (22.29 mM助)
-
SMILESO=C(NC1CCCCC1)NC1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Valdivia C, et al. Bioactive alkenylphenols from Piper obliquum. Bioorg Med Chem. 2008 Apr 1;16(7):4120-6.
molnova catalog
related products
-
D(+)-Glucuronic acid...
Glucuronic acid is a carboxylic acid and highly soluble in water. In humans glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination and to hormones to allow for easier transport.
-
Glucohirsutin
The herbs of Cardamine leucantha.
-
BCPA
BCPA is a non-cytotoxic Pin1 modulator.BCPA modulates osteoclast activation and attenuates the reduction of Pin1 protein, thereby inhibiting RANKL-induced receptor activators of osteoclastogenesis.BCPA is used in the study of osteoporosis.
Cart
sales@molnova.com